Prostate cancer is a disease in which malignant (cancerous) cells form in the tissues of the prostate. The prostate is a gland of the male reproductive system whose function is to make a fluid that is part of semen. The prostate is located below the bladder and surrounds part of the urethra. It is about the size of a walnut.
The incidence of prostate cancer diagnosis varies greatly between different geographical areas, and this may be related to ethnic factors, aging of the population, as the incidence is mainly age-dependent, and the routine use of PSA for prostate cancer screening.
Family and ethnic background are associated with a higher incidence of prostate cancer, suggesting a genetic predisposition to the disease. Hereditary prostate cancer is associated with an earlier disease onset of six to seven years, but disease aggressiveness and clinical course do not appear to differ.
Depending on whether or not the tumor is located within the prostate and the presence of metastases, prostate cancer can be classified into different stages. This classification is important because, depending on the evolution of the tumor, different treatments can be applied:
Prostate cancer and some of its treatments may be associated with various complications:
Prostate cancer in its early stages usually has no symptoms, so the only way to detect it early is through medical check-ups. The main tests are the PSA blood test and digital rectal examination. In advanced stages, symptoms such as difficulty urinating, increased urinary frequency, blood in the urine or bone pain may appear. If you are over 50 years of age, or if you have a family history, it is advisable to see a urologist even if you do not have any discomfort.
Prostate cancer is curable, especially when detected in early stages. If the tumor is localized, cure rates exceed 90% with treatments such as surgery, focal therapy or radiotherapy. In advanced cases, although it is not curable, there are very effective therapies that allow it to be controlled for years. Early detection is essential to increase the chances of cure. For this reason, periodic urological check-ups are recommended from the age of 50 (or earlier if there is a family history).
Robotic surgery is recommended in a variety of situations where its advantages can significantly improve patient outcomes compared to traditional open or laparoscopic surgery. It is considered especially beneficial in complex procedures where high precision and surgical dexterity are required in confined spaces, in patients with comorbidities and/or when urinary or erectile function is sought to be preserved.
It is normal to bleed after a prostate biopsy for one to two weeks, depending on the type of bleeding. There may be blood in the urine, stool and/or semen.
Salvage lymph node dissection in patients with prostate cancer treated with radical prostatectomy or radiotherapy and positive choline positron emission tomography (PET/CT) scan